Previous 10 | Next 10 |
The following slide deck was published by HTG Molecular Diagnostics, Inc. in conjunction with this Read more ...
HTG Molecular (NASDAQ: HTGM ): FY GAAP EPS of -$0.60 beats by $0.10 . More news on: HTG Molecular Diagnostics, Earnings news and commentary, Healthcare stocks news, , Read more ...
TUCSON, Ariz., March 07, 2019 (GLOBE NEWSWIRE) -- HTG Molecular Diagnostics , Inc. (Nasdaq:HTGM) (HTG), a life science company whose mission is to advance precision medicine, today reported its financial results for the year ended December 31, 2018. Recent Accomplishments & Highlig...
TUCSON, Ariz., Feb. 21, 2019 (GLOBE NEWSWIRE) -- HTG Molecular Diagnostics , Inc. (Nasdaq: HTGM), a life science company whose mission is to advance precision medicine, today announced that it will report its financial results for the quarter and year ended December 31, 2018 after the mark...
Gainers: Immune Design (NASDAQ: IMDZ ) +310% . Zosano Pharma Corporation (NASDAQ: ZSAN ) +121% . Adial Pharmaceuticals (NASDAQ: ADIL ) +21% . Grand Canyon Education (NASDAQ: LOPE ) +21% . Attunity (NASDAQ: ATTU ) +19% . Career Education (NASDAQ: CECO ) +18% . Avis Budget Group ...
TUCSON, Ariz., Feb. 21, 2019 (GLOBE NEWSWIRE) -- HTG Molecular Diagnostics , Inc. (Nasdaq: HTGM) (HTG), a life science company whose mission is to advance precision medicine, today announced that TJ Johnson, Chief Executive Officer, will present a corporate overview at the Cowen & Comp...
TUCSON, Ariz., Feb. 20, 2019 (GLOBE NEWSWIRE) -- HTG Molecular Diagnostics , Inc. (Nasdaq: HTGM) (HTG), a diagnostic company whose mission is to advance precision medicine, today announced it has amended its second precision diagnostic partnership program (“PDP Two”) with QIA...
TUCSON, Ariz., Feb. 20, 2019 (GLOBE NEWSWIRE) -- HTG Molecular Diagnostics , Inc. (Nasdaq: HTGM) (HTG), a life science company whose mission is to advance precision medicine, today announced that TJ Johnson, Chief Executive Officer, will present a corporate overview the 8 th Annual SVB Le...
TUCSON, Jan. 07, 2019 (GLOBE NEWSWIRE) -- HTG Molecular Diagnostics , Inc. (Nasdaq: HTGM) (HTG), a life science company whose mission is to advance precision medicine, today announced preliminary, unaudited financial results for the full year ended December 31, 2018. Preliminary Full Ye...
Recent filings for planned equity offerings from healthcare companies: More news on: Vaxart, Inc., Bio-Path Holdings, Inc., Hemispherx Biopharma, Inc, Healthcare stocks news, Stocks on the move, Consumer stocks news, Read more ...
News, Short Squeeze, Breakout and More Instantly...
HTG Molecular Diagnostics Inc. Company Name:
HTGM Stock Symbol:
NASDAQ Market:
HTG Molecular Diagnostics Inc. Website:
TUCSON, Ariz., May 18, 2023 (GLOBE NEWSWIRE) -- HTG Molecular Diagnostics , Inc. (Nasdaq: HTGM) (HTG), a platform-based life science tools and drug discovery company, today announced that its management team will present the advantages of its proprietary drug discovery engine at the 2023 Biot...
TUCSON, Ariz., May 16, 2023 (GLOBE NEWSWIRE) -- HTG Molecular Diagnostics , Inc. (Nasdaq: HTGM) (HTG), a platform-based life science tools and drug discovery company, today reported achievement of another technical milestone in its drug discovery business. HTG is pioneering a proprietar...
TUCSON, Ariz., May 10, 2023 (GLOBE NEWSWIRE) -- HTG Molecular Diagnostics , Inc. (Nasdaq: HTGM) (HTG), a platform-based life science tools and drug discovery company, today reported financial results for the quarter ended March 31, 2023 and provided recent drug discovery business highlig...